Key facts
- This page summarizes John P. Sharp's Form 3 filing for Skye Bioscience, Inc. (SKYE).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Apr 2026, 20:37.
John P. Sharp - 31 Mar 2026 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- SKYE
- Reported as of
- 31 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Apr 2026, 20:37:11 UTC
- Prior SEC filing
- 24 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ John P Sharp
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John P. Sharp filed Form 3 for Skye Bioscience, Inc. (SKYE) on 28 Apr 2026.
Change
- Previous filing in this sequence was filed on 24 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001342894
Primary reporting owner
Sharp John P
- Relationship
- Chief Financial Officer
- Address
- 1250 EL CAMINO REAL, SUITE 100, SAN DIEGO
- Signature
- /s/ John P Sharp
- Signature date
- 28 Apr 2026
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.